![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation Allschwil, Switzerland, June 20, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage...
Basilea verpartnert Onkologie-Wirkstoffkandidat Lisavanbulin mit Glioblastoma Foundation Allschwil, 20. Juni 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches...
Starke Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus Allschwil, 16. Mai 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein...
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea Allschwil, Switzerland, May 16, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX:...
Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024 Allschwil, Switzerland, May 03, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage...
Basilea berichtet über Präsentation neuer Daten zu Ceftobiprol (Zevtera®) auf dem Fachkongress ESCMID Global 2024 Allschwil, 03. Mai 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein...
Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats Allschwil, 24. April 2024 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches...
Basilea shareholders approve all proposals of the board of directors at the annual general meeting Allschwil, Switzerland, April 24, 2024 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 46.2 | 46.2 | 46.2 | 866 | 46.2 | DE |
4 | 0 | 0 | 46.2 | 46.2 | 46.2 | 2070 | 46.2 | DE |
12 | 0 | 0 | 46.2 | 46.2 | 46.2 | 2085 | 46.2 | DE |
26 | 0 | 0 | 46.2 | 46.2 | 46.2 | 2490 | 46.2 | DE |
52 | 0 | 0 | 46.2 | 46.2 | 46.2 | 3795 | 46.2 | DE |
156 | 0 | 0 | 46.2 | 46.2 | 46.2 | 4695 | 46.2 | DE |
260 | 0 | 0 | 46.2 | 46.2 | 46.2 | 4022 | 46.2 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions